1. Academic Validation
  2. Pyruvate Dehydrogenase Kinase 1 inhibition mediated oxidative phosphorylation enhancement in cartilage promotes osteoarthritis progression

Pyruvate Dehydrogenase Kinase 1 inhibition mediated oxidative phosphorylation enhancement in cartilage promotes osteoarthritis progression

  • BMC Musculoskelet Disord. 2023 Jul 20;24(1):597. doi: 10.1186/s12891-023-06585-6.
Xian Yang 1 Qingsong Jiang 1 Tiankuo Luan 2 Chao Yu 3 Zhibo Liu 4 Ting Wang 4 Jingyuan Wan 1 Jiayu Huang 5 Ke Li 6 7
Affiliations

Affiliations

  • 1 Department of Pharmacology, Chongqing Medical University, Chongqing, China.
  • 2 Department of Human Anatomy, Basic Medical School, Chongqing Medical University, Chongqing, China.
  • 3 Department of Orthopedic Surgery, University-Town Hospital of Chongqing Medical University, Chongqing, China.
  • 4 Department of Orthopedic Surgery, The Second Affiliated Hospital of Chongqing, Chongqing, China.
  • 5 Reproductive Medicine Center, The First Affiliated Hospital of Chongqing, Chongqing, China. [email protected].
  • 6 Department of Orthopedics Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China. [email protected].
  • 7 Orthopedic Laboratory of Chongqing Medical University, Chongqing, China. [email protected].
Abstract

Osteoarthritis (OA) is a common disease characterized by cartilage degradation. Growing evidence showed that glucose metabolism impacts joint homeostasis and an imbalance between glycolysis and oxidative phosphorylation (OXPHOS) may exacerbate OA progression, however, a definitive link is yet to be established. Here, we report that pyruvate metabolism and oxidative phosphorylation pathway is enriched in OA cartilage through gene set enrichment analysis (GSEA) and expression of Pyruvate Dehydrogenase Kinase 1 (PDK1), an Enzyme that can phosphorylate Pyruvate Dehydrogenase (PDH), and inhibit pyruvate fluxes into the tricarboxylic acid (TCA) cycle and to OXPHOS, in articular cartilage is notably reduced through destabilization of medial meniscus (DMM). Moreover, by inhibiting PDK1, cartilage loss is markedly accelerated in DMM-induced OA through extracellular matrix (ECM) degradation and Apoptosis of chondrocytes. These results indicate that PDK1 is involved in the progression of OA through accelerating cartilage matrix degradation and synovium inflammation to ameliorate cartilage degeneration.

Keywords

ECM; Glucose metabolism; Inflammation; Osteoarthritis; PDK1.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-19564
    99.88%, PDK Inhibitor